Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2026

Feb 10, 2026

30291_dirs_2026-02-10_2ad18850-20af-4031-b906-dc501f37c7c0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2026-02-06

Reporting Person: Izzar Rachid (Head of Global Product Strat.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-06 Common Stock M 2044 Acquired 8204 Direct
2026-02-06 Common Stock F 805 $201.18 Disposed 7399 Direct
2026-02-06 Common Stock M 1802 Acquired 9201 Direct
2026-02-06 Common Stock F 458 $201.18 Disposed 8743 Direct
2026-02-06 Common Stock M 3043 Acquired 11786 Direct
2026-02-06 Common Stock F 775 $201.18 Disposed 11011 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-06 Restricted Stock Unit $0 M 2044 Disposed 2026-02-08 Common Stock (2044) Direct
2026-02-06 Restricted Stock Unit $0 M 1802 Disposed 2027-02-07 Common Stock (1802) Direct
2026-02-06 Restricted Stock Unit $0 M 3043 Disposed 2028-02-06 Common Stock (3043) Direct

Footnotes

F1: Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order.

F2: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.

F3: The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

F4: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.